Dr. Maeve Hennessy is a medical oncologist specializing in breast oncology. She is currently completing an advanced fellowship in breast oncology at the University of Chicago Medicine. Her clinical focus areas include medical oncology, precision oncology, and perioperative oncology. Her research interests center on biomarker discovery, microbiome–host interactions in oncology, and treatment response prediction with therapy de-escalation to personalize care from diagnosis. Recognized for her contributions, Hennessy was the inaugural recipient of the Breakthrough Cancer Research Fellowship and received the Alavi-Mandell Award from the Society of Nuclear Medicine and Molecular Imaging, with additional support from the European Society for Medical Oncology and the International Cancer Foundation. She has presented at major international forums, including ASCO, ESMO, and the San Antonio Breast Cancer Symposium. She earned her medical degree from University College Dublin, completed Higher Specialist Training in Medical Oncology through the Royal College of Physicians of Ireland, and is now pursuing an advanced fellowship in breast oncology at the University of Chicago Medicine.
Fellow
Medical School
Residency
Fellowship
2025